5/17/2021 12:00:00 AM
The 2021 UK Medtech Roadshow was held on 11 May 2021 as a joint national collaboration between TusPark UK, the Department for International Trade’s (DIT) Life Science and Healthcare Team, Scottish Development International (SDI), and Invest Northern Ireland.
The event was part of the 2021 China International Medical Equipment Fair (CMEF)––the largest fair for medical equipment and related products and services in the Asia-Pacific region—for UK companies in the health sector to network and establish partnerships with local and globally licensed medical equipment distributors, resellers, manufacturers, doctors, regulators, and government agencies.
The roadshow was held to a live audience in TusPark’s headquarters in Beijing, with a livestream to the event open for public attendance, attracting over 50 investors and medical device industry experts onsite and nearly 300 participants online.
11 Life Sciences companies from the UK presented, accompanied by a question and answers. Investors and industry experts expressed their interest in following up after the roadshow with opportunities for future cooperation. A brief introduction of all 11 companies can be found at the end of this article.
China has become the largest Life Science market in the world for a sector that has become the most popular investment focus. The roadshow provided an opportunity for UK companies to present their innovations and attract potential investment and joint work with Chinese partners. It also promoted a bond of cooperation between China and the UK, also offered a platform for UK exhibiting companies to display their brands and innovations in China.
Richard Cowin, Counsellor for Health and Life Sciences at the Department for International Trade, said, “The collaboration in the medical instruments field between the UK and China has become a significant trend in recent years, especially with China’s contribution towards pandemic prevention of COVID-19.”
Meanwhile, TusPark UK hopes to create the most advanced international ecosystem for Life Sciences by combining British innovation with China's R&D abilities, production capacity and rigorous supply chain system.
“Fresh opportunities are opening up in the MedTech sector, driven by the growing need for healthcare systems to deliver greater value, and fuelled by advances in science and the convergence of technologies. TusPark UK is pleased to be a supportive enabler of the collaboration between UK and China, to promote the technology of medical technologies and digital health and bring efficient technologies to the public”, said Kevin Lin, Vice President of TusHoldings and General Manager of TusPark UK.
TusPark UK is committed to forming partnerships between China and the UK in diverse fields, from the Life Science to Clean Energy, AI, Digital and IoT. UK’s innovations can be surfaced to Chinese investors, partners, and more through TusPark’s ecosystem, ensuring maximum impact in this market.
Participating UK Companies
Birthsparks - a UK based (Scotland) private company focused on the establishment of the Comfortable Upright Birth support as a preferred product used by women during late pregnancy and childbirth.
GM Instrument - one of the world’s leading manufacturers of Nasal Congestion Measurement, Respiratory Flow Measurement and Audiometry products.
IVFVision Limited – its digital platform - VFVision.ai, which based on AI/computer vision, can predict which embryos are most likely to lead to pregnancy.
Lightpoint Medical – a technology leader in targeted cancer surgery, aim at developing miniature tools appropriate for minimally invasive and robot-assisted surgery to accurately detect cancer in real-time intra-operatively.
MedEther – a plastic surgery material supplier, aims at developing an artificial intelligence medical device based on deep learning technology that can be used as the alternative therapy to replace invasive surgical procedures for the treatment of moderate to severe signs of skin ageing and scarring.
Nonwovens Innovation & Research Institute Limited - a global leader in nonwoven engineering and product development, having successfully completed over 500 projects for over 200 companies.
Orthox - a clinical stage spin-out from Oxford University, aim to develop an implant able to regenerate new cartilage tissue AND immediately restore cartilage function - FibroFix™ Cartilage.
Oxford Endovascular Ltd - a spin-out from Oxford University, working to treat brain aneurysms. Its product - OxiFlow™️ is a novel, next generation flow-diverter, that diverts blood flow away from intracranial aneurysms at risk of rupture.
Trecco – a company owning advanced Additive Manufacturing methods and state-of-the-art modelling technologies for complex oral, maxillofacial, craniomaxillofacial surgery (CMF) surgery, which can improve patients’ lives. Its cost-effective, Patient-Specific Implants (PSI) and customised surgical guides play an indispensable role in complex reconstruction and neurosurgery operations.
TruCorp – a medical simulation training device company, has been committed to developing anatomically correct products for the medical simulation market.
Randox Toxicology – a world leader in drug screening solutions with the capability of detecting over 500 drug and drug metabolites using our innovative Biochip Array Technology – the most comprehensive on the drug testing market. Our patented Biochip Array Technology works across a variety of matrices, including whole blood, urine, oral fluid, meconium, vitreous humour and hair.